Progress in prophylactic and therapeutic vaccines for human papillomavirus infection (Q35194178)

7 August 2017

1 reference

title

Progress in prophylactic and therapeutic vaccines for human papillomavirus infection (English)

1 reference

Papillomavirus infections

7 August 2017

1 reference

1 reference

Margaret A Stanley

1

1 reference

7 August 2017

1 June 2003

1 reference

Expert Review of Vaccines

7 August 2017

1 reference

7 August 2017

2

1 reference

7 August 2017

3

1 reference

7 August 2017

381-389

1 reference

Papillomaviruses and cancer: from basic studies to clinical application

7 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

Intra-epithelial vaccination with COPV L1 DNA by particle-mediated DNA delivery protects against mucosal challenge with infectious COPV in beagle dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

Induction of type-specific neutralizing antibodies by capsomeres of human papillomavirus type 33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

Intraepithelial DNA immunisation with a plasmid encoding a codon optimised COPV E1 gene sequence, but not the wild-type gene sequence completely protects against mucosal challenge with infectious COPV in beagles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

DNA vaccination prevents and/or delays carcinoma development of papillomavirus-induced skin papillomas on rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2.3.381

21 January 2018

Identifiers

DOI

10.1586/14760584.2.3.381

1 reference

7 August 2017

1 reference

PubMed ID

12903803